Axogen Statistics
Total Valuation
Axogen has a market cap or net worth of $2.14 billion. The enterprise value is $2.06 billion.
Important Dates
The last earnings date was Tuesday, April 28, 2026, before market open.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Axogen has 53.18 million shares outstanding. The number of shares has increased by 6.47% in one year.
| Current Share Class | 53.18M |
| Shares Outstanding | 53.18M |
| Shares Change (YoY) | +6.47% |
| Shares Change (QoQ) | +9.93% |
| Owned by Insiders (%) | 2.40% |
| Owned by Institutions (%) | 82.26% |
| Float | 51.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.00 |
| Forward PS | 7.61 |
| PB Ratio | 8.75 |
| P/TBV Ratio | 9.02 |
| P/FCF Ratio | 230.93 |
| P/OCF Ratio | 137.73 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 222.20 |
Financial Position
The company has a current ratio of 7.10, with a Debt / Equity ratio of 0.08.
| Current Ratio | 7.10 |
| Quick Ratio | 4.99 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 9.41 |
| Debt / FCF | 2.22 |
| Interest Coverage | -1.47 |
Financial Efficiency
Return on equity (ROE) is -17.96% and return on invested capital (ROIC) is -2.55%.
| Return on Equity (ROE) | -17.96% |
| Return on Assets (ROA) | -2.32% |
| Return on Invested Capital (ROIC) | -2.55% |
| Return on Capital Employed (ROCE) | -3.42% |
| Weighted Average Cost of Capital (WACC) | 10.82% |
| Revenue Per Employee | $382,805 |
| Profits Per Employee | -$50,568 |
| Employee Count | 622 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 1.46 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +253.73% in the last 52 weeks. The beta is 1.17, so Axogen's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +253.73% |
| 50-Day Moving Average | 35.41 |
| 200-Day Moving Average | 27.01 |
| Relative Strength Index (RSI) | 54.64 |
| Average Volume (20 Days) | 1,203,358 |
Short Selling Information
The latest short interest is 3.73 million, so 7.01% of the outstanding shares have been sold short.
| Short Interest | 3.73M |
| Short Previous Month | 3.50M |
| Short % of Shares Out | 7.01% |
| Short % of Float | 7.19% |
| Short Ratio (days to cover) | 3.94 |
Income Statement
In the last 12 months, Axogen had revenue of $238.11 million and -$31.45 million in losses. Loss per share was -$0.67.
| Revenue | 238.11M |
| Gross Profit | 178.61M |
| Operating Income | -9.02M |
| Pretax Income | -31.45M |
| Net Income | -31.45M |
| EBITDA | -2.14M |
| EBIT | -9.02M |
| Loss Per Share | -$0.67 |
Full Income StatementBalance Sheet
The company has $101.60 million in cash and $20.64 million in debt, with a net cash position of $80.96 million or $1.52 per share.
| Cash & Cash Equivalents | 101.60M |
| Total Debt | 20.64M |
| Net Cash | 80.96M |
| Net Cash Per Share | $1.52 |
| Equity (Book Value) | 244.81M |
| Book Value Per Share | 4.61 |
| Working Capital | 158.70M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $15.56 million and capital expenditures -$6.28 million, giving a free cash flow of $9.28 million.
| Operating Cash Flow | 15.56M |
| Capital Expenditures | -6.28M |
| Depreciation & Amortization | 6.89M |
| Net Borrowing | -48.62M |
| Free Cash Flow | 9.28M |
| FCF Per Share | $0.17 |
Full Cash Flow StatementMargins
Gross margin is 75.01%, with operating and profit margins of -3.79% and -13.21%.
| Gross Margin | 75.01% |
| Operating Margin | -3.79% |
| Pretax Margin | -13.21% |
| Profit Margin | -13.21% |
| EBITDA Margin | -0.90% |
| EBIT Margin | -3.79% |
| FCF Margin | 3.90% |
Dividends & Yields
Axogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.47% |
| Shareholder Yield | -6.47% |
| Earnings Yield | -1.47% |
| FCF Yield | 0.43% |
Analyst Forecast
The average price target for Axogen is $42.33, which is 5.06% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $42.33 |
| Price Target Difference | 5.06% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 19.23% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Axogen has an Altman Z-Score of 13.22 and a Piotroski F-Score of 4.
| Altman Z-Score | 13.22 |
| Piotroski F-Score | 4 |
